Chemokine expression in the monocytic cell line THP-1 in response to purified Shiga toxin 1 and/or lipopolysaccharides

Infection and Immunity

Volumn 73, Issue 1, 2005, Pages 403-412

  Harrison, Lisa M ^a,b   Van Den Hoogen, Christel ^a   Van Haaften, Wilhelmina C E ^a   Tesh, Vernon L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DACTINOMYCIN; GLOBOTRIAOSYLCERAMIDE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; SHIGA TOXIN; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN 1;

ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; CELL LINE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOKINE GENE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DNA MICROARRAY; GENE EXPRESSION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; LEUKOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; TARGET ORGAN; THP 1 CELL; TISSUE INJURY; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

CELL LINE, TUMOR; CHEMOKINES; CYTOKINES; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEIN-1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SHIGA-LIKE TOXIN I;

EID: 11144297661     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.1.403-412.2005     Document Type: Article

References (53)

1. Auwerx, J. 1991. The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 44:22-31.
2. Cockwell, P., A. J. Howie, D. Adu, and C. O. Savage. 1998. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int. 54:827-836.
3. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
4. Fitzpatrick, M. M., V. Shah, R. S. Trompeter, M. J. Dillon, and T. M. Barratt. 1992. Interleukin-8 and polymorphonuclear leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int. 42:951-956.
5. - mutant of Shigella dysenteriae 1. Infect. Immun. 56:3099-3109.
6. Forsyth, K. D., A. C. Simpson, M. M. Fitzpatrick, T. M. Barratt, and R. J. Levinsky. 1989. Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome. Lancet ii:411-414.
7. 2-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-α. J. Leukoc. Biol. 71:107-114.
8. Fraser, M. E., M. M. Chernaia, Y. V. Kozlov, and M. N. G. James. 1994. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat. Struct. Biol. 1:59-64.
9. Gear, A. R., S. Suttitanamongkol, D. Viisoreanu, R. K. Polanowska-Grabowska, S. Raha, and D. Camerini. 2001. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 97:937-945.
10. Geiser, T., B. Dewald, M. U. Ehrengruber, I. Clark-Lewis, and M. Baggiolini. 1993. The interleukin-8-related chemotactic cytokines GROα, GROβ, and GRO-γ activate human neutrophil and basophil leukocytes. J. Biol. Chem. 268:15419-15424.
11. Goodman, R. B., R. M. Strieter, C. W. Frevert, C. J. Cummings, P. Tekamp-Olson, S. L. Kunkel, A. Walz, and T. R. Martin. 1998. Quantitative comparison of C-X-C chemokines produced by endotoxin-stimulated human alveolar macrophages. Am. J. Physiol. 275:L87-L95.
12. Harrison, L. M., W. C. E. van Haaften, and V. L. Tesh. 2004. Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infect. Immun. 72:2618-2627.
13. Harrold, S., C. Genovese, B. Kobrin, S. L. Morrison, and C. Milcarek. 1991. A comparison of apparent mRNA half-life using kinetic labeling techniques vs. decay following administration of transcriptional inhibitors. Anal. Biochem. 198:19-29.
14. Hurley, B. P., M. Jacewicz, C. M. Thorpe, L. L. Lincicome, A. J. King, G. T. Keusch, and D. W. K. Acheson. 1999. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect. Immun. 67:6670-6677.
15. Hurley, B. P., C. M. Thorpe, and D. W. K. Acheson. 2001. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect. Immun. 69:6148-6155.
16. Inward, C. D., A. J. Howie, M. M. Fitzpatrick, F. Rafaat, D. V. Milford, and C. M. Taylor. 1997. Renal histopathology in fatal cases of diarrhea-associated haemolytic uraemic syndrome. Pediatr. Nephrol. 11:556-559.
17. Jacewicz, M., H. Clausen, E. Nudelman, A. Donohue-Rolfe, and G. T. Keusch. 1986. Pathogenesis of Shigella diarrhea. XI. Isolation of a Shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J. Exp. Med. 163:1391-1404.
18. Lindberg, A. A., J. E. Schultz, M. Westling, J. E. Brown, S. W. Rothman, K.-A. Karlsson, and N. Strömberg. 1986. Identification of the receptor glycolipid for Shiga toxin produced by Shigella dysenteriae type 1, p. 439-446. In D. L. Lark (ed.), Protein carbohydrate interactions in biological systems. Academic Press, London, United Kingdom.
19. 3) expression in human tumour cells: intracellular trafficking defines a new retrograde transport pathway from the cell surface to the nucleus, which correlates with sensitivity to verotoxin. Acta Biochim. Pol. 45:351-359.
20. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. De-Grandis, and M. A. Karmali. 1987. Glycolipid binding of purified and recombinant Escherichia coli-produced verotoxin in vitro. J. Biol. Chem. 262:8834-8839.
21. Liu, J., T. Akahoshi, T. Sasahana, H. Kitasato, R. Namai, T. Sasaki, M. Inoue, and H. Kondo. 1999. Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7. Infect. Immun. 67:6203-6205.
22. Louise, C., and T. G. Obrig. 1991. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-4179.
23. Lukacs, N. W., R. M. Strieter, V. M. Elner, H. L. Evanoff, M. Burdick, and S. L. Kunkel. 1994. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1α during monocyte-endothelial cell interactions. Blood 83:1174-1178.
24. Menten, P., A. Wuyts, and J. van Damme. 2002. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13:455-481.
25. Miyamoto, Y., and S. U. Kim. 1999. Cytokine-induced production of macrophage inflammatory protein-1α (MIP-1α) in cultured human astrocytes. J. Neurosci. Res. 55:245-251.
26. Moxley, R. A., and D. H. Francis. 1998. Overview of animal models, p. 249-260. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
27. O'Brien, J. M., and E. Abraham. 2004. Human models of endotoxemia and recombinant human activated protein C. Crit. Care Med. 32(Suppl. 5):S202-S208.
28. Obrig, T. G., P. J. DelVecchio, J. E. Brown, T. P. Moran, B. M. Rowland, T. K. Judge, and S. W. Rothman. 1988. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect. Immun. 56:2373-2378.
29. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479.
30. Philpott, D. J., C. A. Ackerley, A. J. Killiaan, M. A. Karmali, M. H. Perdue, and P. M. Sherman. 1997. Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am. J. Physiol. 273:G1349-G1358.
31. Proulx, F., E. G. Seidman, and D. Karpman. 2001. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 50:163-171.
32. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
33. Ramegowda, B., J. E. Samuel, and V. L. Tesh. 1999. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J. Infect. Dis. 180:1205-1213.
34. Ruggenenti, P., M. Noris, and G. Remuzzi. 2001. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 60:831-846.
35. Sakiri, R., B. Ramegowda, and V. L. Tesh. 1998. Shiga toxin type 1 activates tumor necrosis factor-α gene transcription and nuclear translocation of the transcriptional activators nuclear factor-κB and activator protein-1. Blood 92:558-566.
36. Sandvig, K., S. Grimmer, S. U. Lauvrak, M. L. Torgersen, G. Skretting, B. van Deurs, and T. G. Iversen. 2002. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell Biol. 117:131-141.
37. Saxena, S. K., A. D. O'Brien, and E. J. Ackerman. 1989. Shiga toxin, Shiga-like toxin II variant and ricin are all single-site RNA N-glycosidases of 28S RNA when microinjected into Xenopus oocytes. J. Biol. Chem. 264:596-601.
38. Shukaliak, J. A., and K. Dorovini-Zis. 2000. Expression of the beta chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture. J. Neuropathol. Exp. Neurol. 59:339-352.
39. Siegler, R. L. 1994. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J. Pediatr. 125:511-518.
40. Slutsker, L., A. A. Ries, K. D. Greene, J. G. Wells, L. Hutwagner, and P. M. Griffin. 1997. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann. Intern. Med. 126:505-513.
41. te Loo, D. M. W. M., L. A. H. Monnens, T. J. A. M. van der Velden, M. A. Vermeer, F. Preyers, P. N. M. Demacker, L. P. W. J. van den Heuvel, and V. W. M. van Hinsbergh. 2000. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95:3396-3402.
42. Tesh, V. L. 1998. Cytokine response to Shiga toxins, p. 226-235. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
43. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
44. Tesh, V. L., J. E. Samuel, L. P. Perera, J. B. Sharefkin, and A. D. O'Brien. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
45. Thorpe, C. M., B. P. Hurley, L. L. Lincicome, M. S. Jacewicz, G. T. Keusch, and D. W. K. Acheson. 1999. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect. Immun. 67:5985-5993.
46. Thorpe, C. M., W. E. Smith, B. P. Hurley, and D. W. K. Acheson. 2001. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect. Immun. 69:6140-6147.
47. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
48. van der Kar, N. C. A. J., L. A. H. Monnens, M. A. Karmali, and V. W. M. van Hinsbergh. 1992. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764.
49. van Setten, P. A., L. A. H. Monnens, R. G. G. Verstraten, L. P. W. J. van den Heuvel, and V. W. M. van Hinsbergh. 1996. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183.
50. van Setten, P. A., V. W. M. van Hinsbergh, L. P. W. J. van den Heuvel, F. Preyers, H. B. P. M. Dukman, K. J. M. Assmann, T. J. A. M. van der Velden, and L. A. H. Monnens. 1998. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patients with hemolytic uremic syndrome. Pediatr. Res. 43:759-767.
51. van Setten, P. A., V. W. M. van Hinsbergh, T. J. A. M. van der Velden, N. C. A. J. van de Kar, M. Vermeer, J. D. Mahan, K. J. M. Assmann, L. P. W. J. van den Heuvel, and L. A. H. Monnens. 1997. Effects of TNF-α on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int. 51:1245-1256.
52. Wozniak, A., W. H. Betts, G. A. Murphy, and M. Rokicinski. 1993. Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 79:608-615.
53. Yamasaki, C., Y. Natori, X.-T. Zeng, M. Ohmura, S. Yamasaki, Y. Takeda, and Y. Natori. 1999. Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by a nontoxic mutant Stx1 which lacks N-glycosidase activity. FEBS Lett. 442:231-234.